Bharat Biotech's Covaxin Gets WHO Approval: The Journey So Far
NDTV
Covaxin has been cleared for use across age groups (18+).
Covaxin was among the first vaccines introduced in the country but there has been a delay in getting a clearance from the World Health Organization (WHO), resulting in Indians, who took the jab, missing out on travelling to many countries. Now, finally, WHO on Wednesday “granted Covaxin an Emergency Use Listing (EUL)”. The vaccine has been cleared for use across age groups (18+). The duration between two shots is of four weeks. The health body hasn't released any information related to vaccine's use on pregnant women and children. ???? WHO has granted emergency use listing (EUL) to #COVAXIN® (developed by Bharat Biotech), adding to a growing portfolio of vaccines validated by WHO for the prevention of #COVID19. pic.twitter.com/dp2A1knGtT
What Is Covaxin?
It's an inactivated whole virus vaccine, containing SARS-CoV-2 particles that have been chemically deactivated. This means these particles can no longer infect cells but can stimulate immune response and make the vaccine suitable for people with compromised immune systems. It comes as a two-dose regimen, recommended to be taken 28 days apart.
